date,title,source
Nov-07-18,"Aridis Pharmaceuticals Announces Publication of Positive AR-301 Phase 1/2a Data in ""Intensive Care Medicine"" and ""The Lancet Respiratory Medicine""",PR Newswire
Nov-13-18,Aridis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Corporate Overview,PR Newswire
